The Revolutionizing Atopic Dermatitis (RAD) meeting took place April 29 through May 1 in Washington, DC, with The American Journal of Managed Care® there to cover the meeting. Some of the top news you may have missed is right below.
These are the top news items from the 2023 Revolutionizing Atopic Dermatitis (RAD) meeting, which took place in Washington, DC, from April 29 to May 1.
Panel Focuses on Burgeoning Therapies in Atopic Dermatitis
A panel held at RAD 2023 reviewed therapies to expect within the next year for the treatment of atopic dermatitis (AD) as well as investigational therapies currently undergoing trials.
Symposium Highlights New Research on JAK, PDE-4 Inhibitors
Janus kinase (JAK) and phosphodiesterase-4 (PDE-4) inhibitors were primary topics covered at the third symposium at the RAD fifth annual conference.
Dr Melinda Gooderham Discusses Emerging Therapies in Atopic Dermatitis
Melinda Gooderham, MSc, MD, FRCPC, dermatologist and clinical researcher at Peterborough Regional Health Centre, discusses emerging topical and biologic therapies expected to be available later this year.
Dr Robert Sidbury: How to Treat Facial Atopic Dermatitis in Infants
Robert Sidbury, MD, MPH, professor of pediatrics at Seattle Children's Hospital, discussed treatment approaches for AD of the face in infancy.
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Study Highlights Significant Increases in Utilization, Spending on DMD Drugs in Medicaid
May 17th 2024The findings add to recent research on the growing utilization, expenditure, and prices of Duchenne muscular dystrophy (DMD) therapies in the current landscape, an area health care policy could potentially address.
Read More